Cargando…
European principles of inhibitor management in patients with haemophilia: implications of new treatment options
Autores principales: | Hermans, C., Giangrande, P. L. F., O’Mahony, B., de Kleijn, P., Bedford, M., Batorova, A., Blatný, J., Jansone, K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444030/ https://www.ncbi.nlm.nih.gov/pubmed/32831110 http://dx.doi.org/10.1186/s13023-020-01511-8 |
Ejemplares similares
-
European principles of inhibitor management in patients with haemophilia
por: Giangrande, P. L. F., et al.
Publicado: (2018) -
Evolution of Haemophilia Care in Europe: 10 years of the principles of care
por: Noone, D., et al.
Publicado: (2020) -
Implications of haemophilia gene therapy for the changing role of the multidisciplinary team
por: Miesbach, Wolfgang, et al.
Publicado: (2021) -
Autologous cell therapy – A new concept to eradicate inhibitors in haemophilia
por: Xie, Hanjing, et al.
Publicado: (2022) -
Haemophilia A associated with Down’s syndrome
por: Kaczorowska-Hac, Barbara, et al.
Publicado: (2012)